Revival of Ethionamide by Alpibectir乙硫异烟胺通过Alpibectir获得新生New England Journal of MedicineIF78.52026-02-190PRE
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trialNATURE MEDICINEIF502024-02-166OAAI
Cell Membrane Transporters Facilitate the Accumulation of Hepatocellular Flucloxacillin Protein Adducts: Implication in Flucloxacillin-Induced Liver InjuryCHEMICAL RESEARCH IN TOXICOLOGYIF3.82020-11-107PREAI
Safety perspectives on presently considered drugs for the treatment of COVID-19目前考虑用于治疗新型冠状病毒肺炎的药物的安全性观点BRITISH JOURNAL OF PHARMACOLOGYIF7.72020-08-1315OAAI
Investigating the importance of individual mitochondrial genotype in susceptibility to drug-induced toxicityBIOCHEMICAL SOCIETY TRANSACTIONSIF4.32020-05-2614OAAI